Juvenile idiopathic arthritis-associated uveitis complicated by glaucoma and Brown's syndrome
SIR, JIA represents the most common form of chronic arthritis in paediatrics. A large population-based German cohort found a prevalence of uveitis in children with JIA of 12% [1] . Whereas secondary glaucoma affects 615% of patients with JIA-associated uveitis [13], Brown's syndrome (restriction of elevation of the adducted eye) is seldom reported [49] . We describe a child with extended oligoarticular JIA who developed secondary glaucoma and Brown's syndrome.
A 7-year-old girl was referred to our centre at 14 months of age with a 1-month history of swelling of the PIP joint of her right fourth finger. Her initial work-up (complete blood count, biochemistry, serology and acute phase reactants) was either normal or negative, with the exception of repeatedly positive ANAs. Over the next few months, swelling of her right fifth finger PIP, right elbow and knees was noted despite ongoing therapy with MTX. Seven months after the disease onset, chronic anterior uveitis was detected on a routine ophthalmologic exam. Topical therapy was started and 4 months later the ocular disease was inactive. She remained in remission with therapy until 1 year later, when she presented to the hospital with fever, polyarthritis and active anterior uveitis. Anti-TNF therapy (etanercept) was added to her treatment, achieving adequate control of her articular and ocular disease.
Due to minor uveitis exacerbations, she was controlled every 3 months at the ophthalmology clinic. Five years after the disease onset, a routine ophthalmologic exam revealed a uveitis flare and elevated intraocular pressure (IOP) of 34 mmHg bilaterally. At that time her articular disease was inactive on MTX and etanercept. Therapy with oral acetazolamide and topical dorzolamide was started with improvement of the IOP. Anti-TNF therapy was modified, switching from etanercept to adalimumab, with rapid control of the uveitis. Unfortunately, IOP increased when a less intensive therapy with carbonic anhydrase inhibitors was used. Bilateral non-perforating deep sclerectomy was performed, her IOP being normal ever since.
The aetiology of her glaucoma could be uveitic vs steroid induced. Several observations spoke against the uveitic aetiology, including the short course of the last episode of uveitis, the lack of anterior synechiae or goniosynechiae and the absence of pigmentary debris at the angle. On the other hand, her age, the antecedent of topical steroid use and the response to topical therapy withdrawal supported the diagnosis of steroid-induced glaucoma.
One week after detection of elevated IOP she presented to the emergency room because of diplopia in the upward gaze. Her eyes were ortophoric in the primary position and on left gaze but on right gaze there was limited elevation in adduction of her left eye (Fig. 1) . In fact, in full adduction the left eye could not be elevated above the midline. An ocular ultrasound and magnetic resonance without gadolinium enhancement did not reveal abnormalities. Due to the suspicion of steroid-induced glaucoma systemic CSs were not prescribed. An intravenous gammaglobulin therapy trial (2 g/kg) was administered without improvement. Adalimumab was reintroduced 1 month after surgery with progressive improvement of ocular mobility. At her last clinic visit, 9 months after development of Brown's syndrome, her ocular mobility was almost normal.
Brown's syndrome may be congenital or acquired [10] . The latter represents a mechanical obstruction to movement of the superior oblique tendon as it passes through the throclea. In rheumatic patients, it is thought to be secondary to tenosynovitis of the superior oblique muscle. It has been previously described in seven patients with JIA [49] (supplementary Table S1 , available as supplementary data at Rheumatology Online), six with the systemic form of the disease (SoJIA) [59] and in patients with other rheumatic conditions such as RA or lupus [10] . In most cases of Brown's syndrome associated with JIA, recent flare-ups or very active articular disease were present before the development of gaze disturbances. Our patient not only did not have SoJIA but also her articular disease remained inactive at the time of presentation. Brown's syndrome, however, developed shortly after detecting a uveitis flare with glaucoma.
FIG. 1 Limitation of elevation of the left eye when it is adducted.
It is well known that patients with JIA may develop tenosynovitis at any location although the eye has rarely been involved. Brown's syndrome represents another ocular complication of JIA and should be treated promptly. It may resolve spontaneously although previous reports have shown that the most efficacious therapy is administration of systemic steroids [4, 5, 79] . Different regimes have been used, from 10 mg every other day orally [5] to pulses of 300 mg i.v. [9] , with good results. The use of steroids resulted in resolution of the symptoms in an interval that varied from 24 h [9] to 2 months [5] .
Therefore, our case represents a typical case of Brown's syndrome ( Fig. 1) with atypical features including the absence of articular activity at the time of presentation, its temporal association with uveitis and steroidinduced glaucoma, and the JIA category, extended oligoarticular instead of systemic.
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